News
Thyrocare Technologies Limited (hereinafter referred to as “THYROCARE” NSE: THYROCARE, BSE: 539871), a leading healthcare ...
Thyrocare Technologies Limited reported a robust 23% year-on-year revenue growth in Q1FY26. The company's core Pathology segment significantly contributed to this surge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback